HIV brain impairment: who gets it, and why?
Cancers in people with HIV: who gets them, and which ones?
Circumcision reduces HIV incidence in Ugandan men and herpes prevalence in South Africans
Superinfection: second HIV infections happen as often as first ones
Novel integrase inhibitor dolutegravir still potent at 96 weeks
Controversy regarding strategic treatment interruptions in young children who start ART during infancy
Tenofovir pro-drug GS-7340 shows good safety and efficacy in short study
